Delhi HC Flags Off-Label Use of Diabetes Drugs for Weight Loss, Seeks CDSCO Report Farhat Nasim3 July 2025 9:27 PM ISTNew Delhi: The Delhi High Court has directed the Central Drugs Standard Control Organisation (CDSCO) and the Drug Controller General of India (DCGI)...
Type 2 diabetes drug improves weight loss, blood sugar in certain Type 1 patients with obesity: Study Dr. Kamal Kant Kohli1 July 2025 8:45 PM ISTA clinical trial led by an Indiana University School of Medicine researcher found that weekly doses of semaglutide - a medication typically prescribed...
Attention Healthcare professionals: WHO Issues Safety Alert on Semaglutide Use Dr. Kamal Kant Kohli1 July 2025 11:19 AM ISTGeneva: The World Health Organization (WHO) has issued a global safety alert highlighting the risk of non-arteritic anterior ischemic optic neuropathy...
Add on Cagrilintide to Semaglutide tied to Significant Weight Loss in diabetics and non diabetics in Obesity Trials Dr. Shravani Dali26 Jun 2025 9:00 AM ISTResearchers have found in phase IIIa REDEFINE 1 trial that Addition of investigational cagrilintide to GLP-1 agonist semaglutide led to 20.4% body...
Weight loss drug: Novo Nordisk Wegovy now available in India Ruchika Sharma25 Jun 2025 3:52 PM ISTMumbai: Novo Nordisk, a global healthcare company headquartered in Denmark, has announced the launch of Wegovy (injectable Semaglutide)...
Intas Gets CDSCO Panel Nod to Conduct Phase III Trial of Semaglutide Injection for Weight Management Parthika Patel17 Jun 2025 6:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has accepted the Bioequivalence (BE)...
Over Rs 2 Cr Semaglutide Theft at Dr Reddy's Srikakulam Unit, Staff Among 8 Arrested Farhat Nasim13 Jun 2025 6:17 PM ISTSrikakulam: In a serious breach of supply chain and internal controls, a group of eight individuals, including current and former pharmaceutical...
Semaglutide increases walking distance in diabetic patients with peripheral artery disease: Lancet Jacinthlyn Sylvia11 Jun 2025 11:00 AM ISTA new study published in The Lancet journal showed that patients with type 2 diabetes and symptomatic peripheral arterial disease were able to walk...
Medical Bulletin 10/June/2025 Dr. Bhumika Maikhuri10 Jun 2025 4:28 PM ISTHere are the top medical bulletins for the day:Study Unveils Effect of Low Calorie Diet on Mental HealthFollowing a low-calorie diet may be linked to...
Diabetes and Weight-Loss Drug Semaglutide Linked to Rare Eye Condition: European Medical Agency Dr. Bhumika Maikhuri10 Jun 2025 8:30 AM ISTThe European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has concluded its review of semaglutide-containing medicines,...
EMA flags rare vision risk with Semaglutide- a active substance in Ozempic, Rybelsus, Wegovy Ruchika Sharma7 Jun 2025 4:52 PM ISTEuropean Medicines Agency (EMA)'s safety committee (PRAC) has concluded its review of medicines containing semaglutide following concerns...
MSN Labs Gets SEC Nod to Conduct Phase III Trial of Semaglutide Dr. Divya Colin4 Jun 2025 3:10 PM ISTNew Delhi: Reviewing the bioequivalence study of the antidiabetic drug Semaglutide of MSN Laboratories, the Subject Expert Committee (SEC) functional...
